LV
Algorae Pharmaceuticals Limited
LVCLF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $27.2M
P/E Ratio -
Div. Yield -
ROE 104.39%
Piotroski F-Score Weak
2/9Valuation
20 /100
Expensive P/B 6.39x
P/E N/A
EV/EBITDA N/A
Growth
46 /100
Stable Book val. growth 4.19%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 67.00%
ROE 104.39%
ROA 63.39%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 25.11x
Int. coverage N/A
Stability
19 /100
Unstable Beta -0.03x
EPS volatility 140.29%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LVCLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Richard Hainsworth
Employees
48
Headquarters
Melbourne